コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 3%) of 27 patients initially managed without retroperitoneal lymph node dissection.
2 ons; surveillance, adjuvant chemotherapy, or retroperitoneal lymph-node dissection.
4 chemotherapy-resistant disease ('desperation retroperitoneal lymph node dissection'), although the re
5 mmended measuring AFP and hCG shortly before retroperitoneal lymph node dissection and at the start o
6 or clinical stage I testis cancer has led to retroperitoneal lymph node dissection being performed mo
9 lk sac tumor and 5% embryonal carcinoma, and retroperitoneal lymph node dissection for clinical stage
10 interest in surveillance rather than primary retroperitoneal lymph node dissection for clinical stage
11 apy and away from radiation, and the role of retroperitoneal lymph node dissection in disseminated no
12 l clinically relevant studies on the role of retroperitoneal lymph node dissection in early and advan
14 odified templates, a bilateral nerve-sparing retroperitoneal lymph node dissection is the treatment o
15 We evaluated men undergoing postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for NSG
19 han reported in men who have a nerve-sparing retroperitoneal lymph node dissection (RPLND) because mo
20 the outcome of patients managed primarily by retroperitoneal lymph node dissection (RPLND) or chemoth
21 r betaHCG, betaHCG more than 100 ng/mL, redo retroperitoneal lymph node dissection (RPLND), and secon
22 needed to facilitate decision making between retroperitoneal lymph node dissection (RPLND), primary c
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。